JMS Co., Ltd. (7702) AI Stock Analysis

• Market Cap: ¥10.60B
• Dividend Yield: 3.85%
• Average Volume (3M): 25.96K
• Price to Earnings (P/E): 31.5
• Beta (1Y): 0.65
• Revenue Growth: 0.38%
• EPS Growth: N/A
• Country: JP
• Employees: 5,283
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 3.52
• Shares Outstanding: 24,733,465
• 10 Day Avg. Volume: 29,090
• 30 Day Avg. Volume: 25,963
• PEG Ratio: -0.37
• Price to Book (P/B): 0.28
• Price to Sales (P/S): 0.16
• P/FCF Ratio: -7.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 54 Neutral
• Price Target: ¥446.00 ▲(0.90% Upside)
• Action: Reiterated Date: 10/30/25
• Date: Action: Reiterated 10/30/25

The overall stock score is primarily influenced by weak financial performance due to low profitability and negative cash flow. Technical indicators suggest a bearish trend, and valuation concerns arise from a negative P/E ratio despite a decent dividend yield. These factors collectively result in a below-average stock score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion.

Gross Profit Margin Improvement

Improved gross margins suggest enhanced cost efficiency and pricing power, contributing to better operational performance.

Stable Balance Sheet

A stable balance sheet with moderate leverage provides financial resilience and flexibility for future investments and growth.

Negative Factors

Negative Free Cash Flow

Negative free cash flow indicates potential issues with capital expenditure management, which could strain financial resources and limit growth opportunities.

Declining Return on Equity

A declining ROE reflects reduced profitability and efficiency in generating returns on shareholders' investments, which may impact investor confidence.

Weak Net Profit Margin

A weak net profit margin suggests challenges in cost management or pricing strategy, potentially affecting long-term profitability and competitiveness.

JMS Co., Ltd. Business Overview & Revenue Model

Company Description

JMS Co.,Ltd. manufactures, sells, exports, and imports medical devices and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with a needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion and syringe pumps, semisolid nutrition feeding devices, blood bags, blood collection scale and mixers, high-frequency tube sealers, and serum collection sets for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon's gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes used in medical institutions. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, accidental needlestick prevention systems, hemodialysis blood tubing sets, dialyzers, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipment, membrane oxygenators, heat exchangers, pacemakers, microcatheters, and cardiopulmonary blood tubing sets. JMS Co.,Ltd. was incorporated in 1947 and is headquartered in Hiroshima, Japan.

How the Company Makes Money

JMS Co., Ltd. generates revenue through multiple streams, primarily by selling its precision instruments and components directly to various sectors such as healthcare, manufacturing, and environmental services. The company's revenue model includes direct sales, partnerships with distributors, and long-term contracts with industrial clients. Additionally, JMS Co., Ltd. benefits from research and development collaborations with other companies and institutions, which can lead to new product innovations and technologies that enhance its market offerings. The company also focuses on after-sales services and support, providing maintenance and calibration services that contribute to ongoing revenue. Strategic partnerships with key industry players help JMS expand its market reach and improve its product portfolio, further driving its earnings.

JMS Co., Ltd. Financial Statement Overview

Summary

JMS Co., Ltd. shows revenue growth and improved gross profit margins, but profitability is weak with a low net profit margin and declining ROE. The balance sheet is stable with moderate leverage, but cash flow management needs improvement due to negative free cash flow.

Income Statement

JMS Co., Ltd. has shown steady revenue growth with a 6.8% increase from 2024 to 2025. The gross profit margin improved to 22.8% in 2025 from 21.6% in 2024. However, net profit margin remains weak at 0.13% for 2025, indicating challenges in cost management or pricing strategy. EBITDA margin slightly improved to 6.9%, suggesting operational improvements but net income volatility impacts profitability.

Balance Sheet

The company maintains a solid equity base with an equity ratio of 50.2% in 2025, reflecting a stable financial structure. The debt-to-equity ratio is moderate at 0.60, indicating manageable leverage. However, return on equity dropped from 2.2% in 2023 to 0.22% in 2025, highlighting reduced profitability on shareholders’ investments.

Cash Flow

Cash flow analysis reveals challenges with negative free cash flow in 2025 at -1.42 billion JPY, down from a positive 498 million JPY in 2024. Operating cash flow to net income ratio is robust at 16.6, suggesting strong cash generation relative to net income, but the negative free cash flow signals a need for better capital expenditure management.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	69.12B	69.75B	65.29B	63.74B	58.17B	57.58B
Gross Profit	15.84B	15.93B	14.09B	14.60B	14.27B	15.10B
EBITDA	4.20B	4.79B	4.08B	4.38B	4.59B	5.64B
Net Income	-277.00M	89.00M	-36.00M	281.00M	826.00M	1.74B
Balance Sheet
Total Assets	80.33B	81.43B	84.71B	74.41B	71.97B	69.08B
Cash, Cash Equivalents and Short-Term Investments	6.20B	5.51B	10.31B	6.33B	6.81B	6.22B
Total Debt	23.36B	24.55B	26.92B	19.75B	18.71B	18.50B
Total Liabilities	40.34B	40.50B	43.96B	35.70B	34.87B	34.09B
Stockholders Equity	39.91B	40.84B	40.57B	38.53B	36.96B	34.84B
Cash Flow
Free Cash Flow	0.00	-1.42B	498.00M	-1.07B	1.14B	481.00M
Operating Cash Flow	0.00	1.47B	3.14B	2.48B	4.40B	3.74B
Investing Cash Flow	0.00	-3.14B	-4.24B	-3.69B	-3.68B	-3.25B
Financing Cash Flow	0.00	-3.19B	4.78B	525.00M	-499.00M	-535.00M

JMS Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 442.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7702, the sentiment is Negative. The current price of 442 is above the 20-day moving average (MA) of 438.15, below the 50-day MA of 442.46, and above the 200-day MA of 436.29, indicating a bearish trend. The MACD of -1.23 indicates Negative momentum. The RSI at 46.32 is Neutral, neither overbought nor oversold. The STOCH value of 72.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7702.

JMS Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7747	68 Neutral	¥836.83B	24.33	11.64%	0.82%	13.53%	-7.39%
4543	67 Neutral	¥3.01T	25.64	8.98%	1.22%	7.68%	10.08%
8086	62 Neutral	¥242.36B	5.59	4.38%	2.03%	6.04%	733.13%
7733	60 Neutral	¥1.51T	38.56	11.34%	1.01%	0.42%	34.76%
3593	55 Neutral	¥143.37B	67.81	0.30%	1.31%	-2.06%	-79.17%
7702	54 Neutral	¥10.60B	31.52	―	3.85%	0.38%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%